Posted by Michael Wonder on 30 Mar 2017
Scott Gottlieb and the credibility of U.S. therapeutics
29 March 2017 - President Donald Trump has nominated Scott Gottlieb as U.S. Commissioner of Food and Drugs.
The Trump administration’s approach to the FDA is guided by a libertarian belief in markets over science, and Gottlieb apparently shares this view. He has argued that the agency displays an “unreasonable hunger for statistical certainty” and a “profound lack of confidence in the ability of doctors to make careful judgments.” He seems poised to weaken phase 3 testing requirements.
The administration considered nominees with even more extreme views, including the belief that the FDA should not be in the business of regulating drug efficacy.
